Shareholder of Company (MRX) plans sale of 57,709 common shares
Rhea-AI Filing Summary
A shareholder of MRX has filed a notice of proposed sale of 57,709 shares of common stock, to be sold through Goldman Sachs & Co. LLC, with an approximate sale date of January 7, 2026 on the NASD market. The issuer had 71,231,706 shares of common stock outstanding at the time referenced. The shares to be sold were acquired mainly as restricted stock unit compensation from the issuer between 2021 and 2024, along with shares bought directly from the issuer in private and public transactions.
During the three months before this notice, Thomas Hugues Texier sold 4,285 shares of common stock on each of October 6, 2025, November 3, 2025, and December 1, 2025, for gross proceeds of $126,060.60, $132,468.83, and $150,659.49, respectively.
Positive
- None.
Negative
- None.
FAQ
What does the MRX Form 144 filing disclose?
The Form 144 filing discloses that a shareholder of MRX intends to sell 57,709 shares of common stock through Goldman Sachs & Co. LLC, with an approximate sale date of January 7, 2026 on NASD.
What MRX stock sales occurred in the three months before this notice?
Over the prior three months, Thomas Hugues Texier sold 4,285 shares of MRX common stock on each of October 6, 2025, November 3, 2025, and December 1, 2025, with gross proceeds of $126,060.60, $132,468.83, and $150,659.49, respectively.
What representation does the selling person make in the MRX Form 144?
By signing the notice, the selling person represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.